MedPath

PLASMALYTE 148 IN 5% DEXTROSE INJ

PLASMALYTE 148 IN 5% DEXTROSE INJ

Discontinued
DIN Number

00260592

Drug Class

Human

Market Date

Dec 31, 1958

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00260592
AIG Number0600060003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BB02 ELECTROLYTES WITH CARBOHYDRATES
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

DEXTROSEActive
Strength: 5 G / 100 ML
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 30 MG / 100 ML
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 37 MG / 100 ML
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 368 MG / 100 ML
Monograph: SODIUM ACETATE
SODIUM CHLORIDEActive
Strength: 526 MG / 100 ML
Monograph: SODIUM CHLORIDE
SODIUM GLUCONATEActive
Strength: 502 MG / 100 ML
Monograph: SODIUM GLUCONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.